Guardant Health (GH) Tops Q3 EPS by 30c

Guardant Health (NASDAQ: GH) reported Q3 EPS of ($0.67), $0.30 better than the analyst estimate of ($0.97). Revenue for the quarter came in at $143 million versus the consensus estimate of $137.35 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.

You May Also Be Interested In

• Mizuho upgrades Bloom Energy to Outperform on stronger execution, margin expansion
• Anavex Life Sciences (AVXL) Tops Q2 EPS by 2c
• Diana Shipping (DSX) Tops Q2 EPS by 10c